Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Wilms Tumor 6 Lymphoma, Non-Hodgkin 6 Rhabdoid Tumor 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Neuroblastoma 5 Medulloblastoma 5 Histiocytosis, Langerhans-Cell 5 Hepatoblastoma 5 Glioma 5 Ependymoma 5 Sarcoma 4 Rhabdomyosarcoma 4 Osteosarcoma 4 Lymphoma 4 Central Nervous System Neoplasms 4 Sarcoma, Ewing 3 Multiple Myeloma 3 Lung Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroendocrine Tumors 2 Malignant Solid Neoplasm 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Xanthogranuloma, Juvenile 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

Gemcitabine 43 pembrolizumab 36 Paclitaxel 36 Nivolumab 30 Docetaxel 29 Capecitabine 29 Bevacizumab 29 Oxaliplatin 28 Fluorouracil 28 Cisplatin 26 Leucovorin 24 Cyclophosphamide 23 Radiosurgery 20 Irinotecan 20 Carboplatin 20 aldesleukin 19 Cetuximab 18 Interleukin-2 16 fludarabine phosphate 15 fludarabine 15 Pemetrexed 15 Trastuzumab 14 Ipilimumab 14 Fulvestrant 14 130-nm albumin-bound paclitaxel 14 Prednisone 13 Magnetic Resonance Spectroscopy 13 Everolimus 13 Radiotherapy 12 Panitumumab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neoplasm Metastasis × X-Rays × Clear all

NCT03842228 2026-04-29

COD

National Cancer Institute (NCI)

Phase 1 Active not recruiting

39 enrolled 15 charts

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡